Reckitt Benckiser to pay $1.4bn over opioid treatment sales
12-07-2019
Fed Circuit refusal paves way for Suboxone generics
05-02-2019
brianpirwin / Shutterstock.com
Indivior has launched a generic version of its opioid addiction drug Suboxone (buprenorphine and naloxone) Film, one day after the US Supreme Court denied its request to put a lower court’s ruling on hold.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Indivior, generics, Suboxone, Dr Reddy’s, patent infringement, opioid addiction, ANDA, FDA, US Supreme Court
